Market Insights Health Pharmaceuticals Vaccines

Other Vaccines - Uzbekistan

Uzbekistan

In Uzbekistan, the revenue in the Other Vaccines market is projected to reach US$14.05m in 2024.
It is expected to show an annual growth rate (CAGR 2024-2029) of 13.03%, resulting in a market volume of US$25.92m by 2029.
Comparatively, United States is anticipated to generate the highest revenue in the global market, amounting to US$24,730.00m in 2024.
Uzbekistan is witnessing a surge in demand for other vaccines, driven by an increasing awareness of the importance of preventive healthcare among its population.

Key regions: Australia, Brazil, United Kingdom, Europe, Canada

Market

Region

Region comparison

Currency

Analyst Opinion

The Other Vaccines market in Uzbekistan has been steadily growing in recent years.

Customer preferences: Uzbekistan has a population of over 30 million people, and the government has made efforts to improve the country's healthcare system. The country has a mandatory vaccination program for children, which includes vaccines for polio, measles, and hepatitis B. However, there is also a growing demand for other vaccines, particularly among adults who are looking to protect themselves against diseases such as influenza and pneumonia.

Trends in the market: One of the main trends in the Other Vaccines market in Uzbekistan is the increasing availability of vaccines. The government has been working to improve access to healthcare services in the country, and this has included increasing the number of healthcare facilities that offer vaccines. In addition, there has been a growing number of private clinics that offer vaccinations, which has increased competition in the market and made vaccines more affordable for consumers.Another trend in the market is the increasing popularity of travel vaccines. Uzbekistan is a popular destination for tourists, and many visitors are required to have certain vaccinations before entering the country. This has led to an increase in demand for travel vaccines, such as those for yellow fever and typhoid.

Local special circumstances: One of the key factors driving the growth of the Other Vaccines market in Uzbekistan is the country's geography. Uzbekistan is located in Central Asia, and the region is known for its harsh climate and extreme temperatures. This has led to a higher incidence of certain diseases, such as influenza and pneumonia, which has increased demand for vaccines.In addition, Uzbekistan has a large population of migrant workers, who often come from countries with high rates of infectious diseases. This has led to an increased demand for vaccines among this population, particularly for diseases such as hepatitis B and tuberculosis.

Underlying macroeconomic factors: The growth of the Other Vaccines market in Uzbekistan is also being driven by the country's improving economy. Uzbekistan has been implementing economic reforms in recent years, which have led to increased investment in healthcare infrastructure. This has helped to improve the availability and affordability of vaccines in the country.In addition, the government has been working to improve the country's healthcare system, which has included increasing the number of healthcare workers and improving the quality of healthcare services. This has helped to increase consumer confidence in the healthcare system and has led to increased demand for vaccines.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.